Anchor Therapeutics Company
Anchor Therapeutics develops pharmaceutical candidates to address cancer, inflammation, metabolism, heart disease, and pain.
Employee Number:
11-50
Funding Status:
Early Stage Venture
Headquarters:
Cambridge, Massachusetts, United States
Technology:
Data-driven Technologies
Estimated Revenue:
$1M to $10M
Founded Date:
2006
Industry:
PharmTech